查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606328

腦血管攝影市場：按產品、給藥途徑、應用和最終用戶 - 全球預測 2025-2030

Cerebral Angiography Market by Product (Computed Tomography Angiography, Magnetic Resonance Angiography, X-ray Angiography), Route of Administration (Transfemoral, Transradial), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腦血管攝影市場價值為14.1億美元，預計到2024年將達到15.1億美元，複合年成長率為6.85%，到2030年預計將達到22.5億美元。

腦血管攝影是一種可視化大腦血管的診斷影像技術，在各種神經系統疾病（包括動脈瘤、中風和血管畸形）的診斷和治療中發揮至關重要的作用。腦血管攝影的需求在於其能夠提供腦血管系統的詳細影像，從而實現準確的評估和干涉計劃。其應用範圍廣泛，包括醫院、專科診所和研究機構，用於診斷和治療目的。最終用途範圍廣泛，包括在神經科、介入放射學單位和神經血管疾病研究中越來越多的使用。推動市場成長的主要因素是腦血管疾病盛行率的上升、影像處理系統的技術進步以及對微創手術的需求不斷增加。潛在的機會包括開發可攜式且經濟高效的成像解決方案、增強數位成像技術以及改進顯影劑以獲得更清晰、更安全的影像。對用於影像分析的人工智慧的投資以及用於預測診斷的機器學習的整合指向了重要的成長途徑。然而，市場擴張面臨高昂的治療成本、嚴格的監管核准以及對熟練醫務人員的需求的挑戰。此外，低收入地區的進入有限也是採用的障礙。為了應對這些挑戰，技術創新可以專注於降低成本、擴大遠距遠端醫療能力以及為醫務人員制定培訓計劃。在不斷的技術進步以及醫療保健提供者和高科技公司之間的合作夥伴關係的推動下，市場競爭激烈且充滿活力。企業可以透過投資人工智慧主導的診斷工具的研發和加強跨部門合作來利用新興趨勢。透過解決當前的限制並專注於這些創新領域，相關人員可以利用腦血管攝影市場的成長潛力，確保改善患者的治療效果和市場擴張。

主要市場統計
基準年[2023] 14.1億美元
預測年份 [2024] 15.1億美元
預測年份 [2030] 22.5億美元
複合年成長率（%） 6.85%

市場動態：快速發展的腦血管攝影市場的關鍵市場洞察

供需的動態交互作用正在改變腦血管攝影市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 腦血管疾病和損傷的發生率增加
    • 偏好微創手術或影像導引手術
    • 提高對腦​​部疾病的認知和早期診斷的舉措
  • 市場限制因素
    • 血管造影術手術的複雜醫療費用
  • 市場機會
    • 腦血管攝影技術進展
    • 對混合血管造影術成像系統的需求不斷成長
  • 市場挑戰
    • 接受腦血管攝影可能產生的副作用

波特五力：駕馭腦血管攝影市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對腦血管攝影市場的影響

外部宏觀環境因素對腦血管攝影市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解腦血管攝影市場競爭狀況

對腦血管攝影市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣腦血管攝影市場廠商績效評估

FPNV定位矩陣是評估腦血管攝影市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了腦血管攝影市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，腦血管攝影市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腦血管疾病和創傷的發生率增加
      • 優先考慮微創手術和影像導引手術
      • 努力提高對腦部疾病的認知和早期診斷
    • 抑制因素
      • 血管造影術複雜報銷
    • 機會
      • 腦血管攝影技術進展
      • 對混合血管造影術成像系統的需求不斷成長
    • 任務
      • 接受腦血管攝影的潛在副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章腦血管攝影市場：依產品

  • 電腦斷層血管造影術
  • 磁振血管造影術
  • X血管造影術

第7章腦血管攝影市場：依給藥途徑

  • 經股骨
  • 經橈動脈

第8章腦血管攝影市場：依應用分類

  • 診斷
  • 治療藥物

第9章腦血管攝影市場：依最終用戶分類

  • 門診手術中心
  • 醫院/診所

第10章北美與南美腦血管攝影市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區腦血管攝影市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的腦血管攝影市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Cook Group Incorporated
  • GE Healthcare Technologies Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • InterMed Medical Limited
  • Koninklijke Philips NV
  • MEDTRON AG
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers company
  • St. Stone Medical Devices Private Limited
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-8E22B619330B

The Cerebral Angiography Market was valued at USD 1.41 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 2.25 billion by 2030.

Cerebral angiography, a diagnostic imaging technique used to visualize blood vessels in the brain, plays a pivotal role in the diagnosis and management of various neurological conditions, including aneurysms, strokes, and vascular malformations. The necessity for cerebral angiography stems from its ability to provide detailed images of cerebral vasculature, enabling precise assessment and intervention planning. Its applications extend across hospitals, specialized clinics, and research institutions, serving both diagnostic and therapeutic purposes. The end-use scope is broad, encompassing neurology departments, interventional radiology units, and increasing utilization in research on neurovascular diseases. Market growth is primarily driven by rising incidences of cerebrovascular diseases, technological advancements in imaging systems, and the increasing demand for minimally invasive procedures. Potential opportunities lie in developing portable and cost-effective imaging solutions, enhancing digital imaging technologies, and improving contrast agents for better image clarity and safety. Investments in artificial intelligence for image analysis and integration of machine learning for predictive diagnostics represent a significant growth avenue. However, market expansion is challenged by high procedure costs, stringent regulatory approvals, and the need for skilled healthcare professionals. Additionally, limited access in low-income regions poses a barrier to widespread adoption. To address these challenges, innovation can focus on reducing costs, expanding telemedicine capabilities, and developing training programs for medical staff. The nature of the market is competitive and dynamic, driven by continuous technological evolution and partnerships among healthcare providers and tech companies. Companies can capitalize on emerging trends by investing in R&D for AI-driven diagnostic tools and enhancing cross-disciplinary collaborations. By addressing current limitations and focusing on these areas of innovation, stakeholders can harness the growth potential within the cerebral angiography market, ensuring improved patient outcomes and expanded market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 1.41 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 2.25 billion
CAGR (%) 6.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebral Angiography Market

The Cerebral Angiography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cerebrovascular diseases and injuries
    • Preference for minimally invasive and image-guided surgeries
    • Initiatives to raise awareness and early diagnosis of brain disorders
  • Market Restraints
    • Complex reimbursement for angiography procedures
  • Market Opportunities
    • Technological advancements in cerebral angiography
    • Expanding demand for hybrid angiography imaging systems
  • Market Challenges
    • Potential side effects of undergoing cerebral angiography

Porter's Five Forces: A Strategic Tool for Navigating the Cerebral Angiography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebral Angiography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebral Angiography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebral Angiography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebral Angiography Market

A detailed market share analysis in the Cerebral Angiography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebral Angiography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebral Angiography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebral Angiography Market

A strategic analysis of the Cerebral Angiography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebral Angiography Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health, Inc., Carestream Health, Inc., Cook Group Incorporated, GE Healthcare Technologies Inc., Hitachi Medical Corporation, Hologic, Inc., InterMed Medical Limited, Koninklijke Philips N.V., MEDTRON AG, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Samsung Medison Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, St. Stone Medical Devices Private Limited, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cerebral Angiography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Computed Tomography Angiography, Magnetic Resonance Angiography, and X-ray Angiography.
  • Based on Route of Administration, market is studied across Transfemoral and Transradial.
  • Based on Application, market is studied across Diagnostics and Therapeutics.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cerebrovascular diseases and injuries
      • 5.1.1.2. Preference for minimally invasive and image-guided surgeries
      • 5.1.1.3. Initiatives to raise awareness and early diagnosis of brain disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Complex reimbursement for angiography procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cerebral angiography
      • 5.1.3.2. Expanding demand for hybrid angiography imaging systems
    • 5.1.4. Challenges
      • 5.1.4.1. Potential side effects of undergoing cerebral angiography
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cerebral Angiography Market, by Product

  • 6.1. Introduction
  • 6.2. Computed Tomography Angiography
  • 6.3. Magnetic Resonance Angiography
  • 6.4. X-ray Angiography

7. Cerebral Angiography Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Transfemoral
  • 7.3. Transradial

8. Cerebral Angiography Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Therapeutics

9. Cerebral Angiography Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals & Clinics

10. Americas Cerebral Angiography Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cerebral Angiography Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cerebral Angiography Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AngioDynamics, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. Boston Scientific Corporation
  • 6. Canon Medical Systems Corporation
  • 7. Cardinal Health, Inc.
  • 8. Carestream Health, Inc.
  • 9. Cook Group Incorporated
  • 10. GE Healthcare Technologies Inc.
  • 11. Hitachi Medical Corporation
  • 12. Hologic, Inc.
  • 13. InterMed Medical Limited
  • 14. Koninklijke Philips N.V.
  • 15. MEDTRON AG
  • 16. Medtronic PLC
  • 17. Merit Medical Systems, Inc.
  • 18. MicroPort Scientific Corporation
  • 19. Penumbra, Inc.
  • 20. Samsung Medison Co., Ltd.
  • 21. Shimadzu Corporation
  • 22. Siemens Healthineers company
  • 23. St. Stone Medical Devices Private Limited
  • 24. Stryker Corporation
  • 25. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. CEREBRAL ANGIOGRAPHY MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBRAL ANGIOGRAPHY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEREBRAL ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBRAL ANGIOGRAPHY MARKET DYNAMICS
  • TABLE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COMPUTED TOMOGRAPHY ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MAGNETIC RESONANCE ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY X-RAY ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY TRANSRADIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023